Cotinga Pharmaceuticals Inc.
COTQF
$0.0001
$0.000.00%
OTC PK
| 01/31/2020 | 10/31/2019 | 07/31/2019 | 04/30/2019 | 01/31/2019 | |
|---|---|---|---|---|---|
| Net Income | 0.05% | -2.24% | 43.87% | -236.36% | 44.65% |
| Total Depreciation and Amortization | 0.00% | -1.57% | -24.40% | -18.05% | -2.84% |
| Total Amortization of Deferred Charges | 0.00% | -3.13% | 3.23% | -- | -- |
| Total Other Non-Cash Items | 0.93% | 46.36% | -84.99% | 793.90% | -38.11% |
| Change in Net Operating Assets | 13.31% | 45.95% | -61.35% | 154.30% | 379.28% |
| Cash from Operations | 39.52% | 48.24% | -161.90% | -625.00% | 103.21% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 100.00% | 83.08% |
| Cash from Investing | -- | -- | -- | 100.00% | 83.08% |
| Total Debt Issued | -22.73% | 10.00% | -50.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Financing | -22.26% | 107.75% | -73.35% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 218.75% | 94.11% | -263.73% | 609.40% | 102.89% |